Medications for Chronic Venous Insufficiency
Compression therapy is the mainstay of treatment for chronic venous insufficiency (CVI), while pharmacological options like diosmin can provide additional symptomatic relief. 1
First-Line Treatment: Compression Therapy
Compression therapy is widely recognized as the primary conservative treatment for CVI and should be implemented before or alongside pharmacological interventions:
Recommended pressure levels:
- Minimum pressure of 20-30 mmHg for mild to moderate CVI
- Higher pressures of 30-40 mmHg for more severe disease 1
Types of compression:
- Compression stockings (most common)
- Compression bandages
- Compression pumps
Application considerations:
- Higher pressure at the calf compared to distal ankle (negative graduated compression) provides better ejection fraction in refluxing vessels 1
- Proper fitting and patient education are essential for adherence
Pharmacological Options
Flavonoids
Diosmin (Vasculera/Diosmiplex):
- FDA-approved medical food for CVI management
- Dosage: 600 mg daily for general CVI manifestations 2
- For hemorrhoidal disease: 1 tablet 3 times daily for 4 days, then 1 tablet twice daily for 9 days, followed by maintenance dose of 600 mg daily 2
- Mechanism: Manages venous inflammation, reduces accumulation of leukocytes and platelets, and decreases edema 2
- Adverse effects: Generally mild, including gastrointestinal disturbances (7%) and headaches 2
Other flavonoids:
Treatment Algorithm Based on CVI Severity
Mild CVI (C1-C2: telangiectasias, reticular veins, varicose veins)
- Compression stockings (20-30 mmHg)
- Consider diosmin 600 mg daily if symptoms persist
Moderate CVI (C3-C4: edema, skin changes)
- Compression stockings (30-40 mmHg)
- Diosmin 600 mg daily
- Consider referral to vascular specialist if symptoms are not adequately controlled
Severe CVI (C5-C6: healed or active venous ulcers)
- Compression therapy (30-40 mmHg)
- Diosmin 600 mg daily
- Appropriate wound care for ulcers
- Referral to vascular specialist for consideration of interventional therapies 5
Important Considerations and Pitfalls
Compression therapy limitations:
- Despite being first-line treatment, patient adherence is often poor
- Evaluate for arterial disease before prescribing compression (16% of patients with venous ulcers have concomitant arterial occlusive disease) 1
Pharmacological therapy caveats:
When to refer:
- Patients with more severe manifestations of CVI should be referred to a vascular subspecialist for consideration of interventional therapies 5
- Interventional options include endovenous thermal ablation, ultrasound-guided foam sclerotherapy, and surgical approaches for patients with significant reflux 6
By implementing this treatment approach, focusing on compression therapy as the foundation and adding appropriate pharmacological management, most patients with CVI can achieve significant symptom improvement and prevention of disease progression.